Donor lymphocyte infusion as therapy for persistent pure red cell aplasia following major ABO-incompatible stem cell transplantation

被引：0
|
作者：
Lubking, A. [1 ]
Winqvist, I. [1 ]
Lenhoff, S. [1 ]
机构：
[1] Lund Univ, Lund, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S373 / S373
页数：1
相关论文
共 50 条
  • [1] Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation
    Zhu, Panpan
    Wu, Yibo
    Cui, Dawei
    Shi, Jimin
    Yu, Jian
    Zhao, Yanmin
    Lai, Xiaoyu
    Liu, Lizhen
    Xie, Jue
    Huang, He
    Luo, Yi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
    Bolan, CD
    Leitman, SF
    Griffith, LM
    Wesley, RA
    Procter, JL
    Stroncek, DF
    Barrett, AJ
    Childs, RW
    BLOOD, 2001, 98 (06) : 1687 - 1694
  • [3] Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation
    Zhu, Kang-Er
    Li, Jun-Ping
    Zhang, Tao
    Zhong, Juan
    Chen, Jie
    HEMATOLOGY, 2007, 12 (02) : 117 - 121
  • [4] Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study
    Longval, Thomas
    Galimard, Jacques-Emmanuel
    Lepretre, Anne-Claire
    Suarez, Felipe
    Amiranoff, Denise
    Cazaux, Marine
    Kaphan, Eleonore
    Michonneau, David
    Dhedin, Nathalie
    Coman, Tereza
    Quoc, Stephanie Nguyen
    de Latour, Regis Peffault
    Resche-Rigon, Matthieu
    de Fontbrune, Flore Sicre
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (04) : 814 - 826
  • [5] Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu, Kanger
    Li, Jun-ping
    Zhang, Tao
    BLOOD, 2006, 108 (11) : 401B - 401B
  • [6] Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation
    Fang, Baijun
    Song, Yongping
    Li, Ning
    Li, Jing
    Han, Qin
    Zhao, Robert Chunhua
    ANNALS OF HEMATOLOGY, 2009, 88 (03) : 261 - 266
  • [7] Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation
    Baijun Fang
    Yongping Song
    Ning Li
    Jing Li
    Qin Han
    Robert Chunhua Zhao
    Annals of Hematology, 2009, 88 : 261 - 266
  • [8] Pure red cell aplasia (PRCA) following ABO-incompatible allogeneic bone marrow transplantation
    Sethi, S
    Hamadani, MH
    Kamble, R
    Kharfan-Dabaja, M
    Ozer, H
    Selby, GS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 38 - 38
  • [9] Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation
    Bavaro, P
    Di Girolamo, G
    Olioso, P
    Papalinetti, G
    Iacone, A
    Accorsi, P
    Di Bartolomeo, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) : 930 - 931
  • [10] Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematropoietic cell transplantation
    Booth, Garrett S.
    Savani, Bipin N.
    Langston, Amelia A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (04) : 701 - 702
12345